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Bipolar disorder (BP) is a highly heritable disorder, however
attempts to map genetic risk factors are challenging. One possi-
ble reason for these difficulties is the genetic heterogeneity of BP.
Hence, focusing on clinically homogeneous families to create a
genetically more homogeneous sample may increase the power of
finding a specific variant. Alcohol abuse (AA) and alcohol
dependence (AD) are familial in BP families, and these families
may carry a specific risk variant for BP. We tested this hypothesis
by performing a genome-wide linkage scan in 638 pedigrees
(1,835 individuals) from the National Institute of Mental Health
Genetics Initiative for BP, weighting the evidence for linkage
according to the family’s frequency of AA or AD. Using AA
weighting, we identified a linkage region on 9p22.2 with an NPL
score of 3.23. The region had previously been identified in a meta-
analysis of linkage in bipolar disorder. We used permutation
analysis to assess if weighting by AA increased the linkage signal
more than expected by chance and observed a significant P-value
(P¼ 0.048). Therefore, the genetic risk factor for BP on 9p22.2
has an increased effect in families with high levels of AA. In
summary, we present an example of using covariates such as AA
and AD to define subtypes of BP, demonstrate how using such
subtypes can improve the power of a linkage scan, and demon-
strate statistical approaches to validate the suggested interaction.
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Bipolar disorders (BP) are recurrent, episodic disorders of mood
characterized by manic or hypomanic and depressive episodes
affecting 1–2% of the population [Merikangas et al., 2007]. BP
has concordance rates of 67% in monozygotic twins and 20% in
dizygotic twins and first-degree relatives [Bertelsen et al., 1977] and
an estimated heritability of 59–87% [Smoller and Finn, 2003].
Linkage studies in BP have had promising, but mixed, results.
Three recent meta-analyses of BP linkage studies show evidence
for linkage in six different areas: chromosome 9p and 10q
[Segurado et al., 2003], 13q and 22q [Badner and Gershon,
2002], and 6q and 8q [McQueen et al., 2005]. One possible reason
for disparate findings in different studies is clinical heterogeneity
in the diagnosis of BP [Kelsoe, 2003]. If such clinical heterogeneity
is the effect of multiple underlying risk alleles, families will segregate
different risk alleles and thus provide conflicting information.
Under this model, concentrating the analysis on families that carry
a specific variant will increase the power of these studies substan-
tially. One approach to identify such a subset of families is to study
linkage in a more clinically homogeneous sample. Recent linkage
studies of BP have used this approach with age of onset [Faraone
et al., 2004; Lin et al., 2005; Zandi et al., 2007], comorbid anxiety
[Zandi et al., 2007], comorbid panic disorder [MacKinnon et al.,
1998; Cheng et al., 2006], psychosis [Potash et al., 2003; Cheng et al.,
2006; Zandi et al., 2007], and suicidal behavior [Cheng et al., 2006;
Willour et al., 2007].
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Here we explore BP in comorbidity with alcohol abuse (AA) or
alcohol dependence (AD). AA is defined as continued drinking
despite social, legal or interpersonal problems; AD includes physi-
ological tolerance or withdrawal [APA, 2000]. We differentiate
between AA and AD because the categories describe different
patterns of use: AA can occur when an individual uses alcohol in
a manner that seriously interferes with their lives. It may be
intermittent, for example in a binge-drinking fashion only during
manias or represent a persistent maladaptive pattern of over use,
for example, frequent but predictable heavy use with notable
personal consequences. Alcohol dependence, on the other hand,
describes a level of chronic use that results in physiological
consequences (e.g., tolerance) with overwhelming psychological
cravings and a repertoire of behaviors centered around using
alcohol. Furthermore AA and AD diagnoses describe distinct
long-term behavioral patterns; in prospective studies only 3.5%
of AA subjects develop AD within 5 years, comparable to 2.5%
incidence of AD in subjects with no alcohol-related diagnosis
[Schuckit et al., 2001]. Thus, AA is not simply a ‘‘first step’’ to
AD, but a different pattern of drinking that persists over time.
AA is comorbid with any BP at a rate of 39.1%; AD at a rate of
23.2% [Merikangas et al., 2007], these rates are twice as high as those
in the general population [Hasin et al., 2007]. In a prospective
cohort study, risk of AA was increased by pre-existing manic
symptoms (OR 2.4 (95% CI 1.2–4.8)), and by a pre-existing
diagnosis of BPII (OR 9.1 (95% CI 27–31.2)). The risk of AD was
also increased by pre-existing manic symptoms (OR 4.4 (95% CI
1.6–12.7)), and by pre-existing BPII (OR 21.1 (95% CI 6.6–67.5))
[Merikangas et al., 2008]. Clinically, comorbidity of AA/AD with
BP is detrimental to the patient in more ways than the added
burden of disease. AA/AD is correlated with higher rates of
suicidality [Potash et al., 2000; Baldassano, 2006] and increased
number of hospitalizations [Cassidy et al., 2001], a less favorable
response to lithium [Goldberg et al., 1999] and rapid-cycling
[McKowen et al., 2005].
The genetic predisposition to alcoholism has been hypothesized
to constitute part of the genetic predisposition to bipolar disorder
and vice versa [Winokur et al., 1996, 1998], and this genetic overlap
explains the greater propensity for developing both BP and AA/AD.
Heritability estimates of AA/AD based on twin studies have been as
high as 50–60% [Prescott, 2001]. Furthermore, we and others
found AA/AD to be familial in bipolar disorder, indicating that
the increased comorbidity may be related to heritable causes
[Winokur et al., 1996; Schulze et al., 2006; Nurnberger et al.,
2007; Potash et al., 2007; Saunders et al., 2008]. Evidence of
heritability for AA/AD and BP, combined with studies of familiality
suggest nonlinear interaction of AA/AD and genetic risk variants
for BP. In this model such risk variants will be more common
in families with large number of members with AA/AD. Thus,
we expect stronger signals for linkage in families with high levels
of AA or AD. We tested this hypothesis by weighting the evidence
for linkage in each family according to the family’s frequency of AA
or AD. We consider AA and AD separately because they describe
differing, enduring patterns of drinking behavior that may have
different genetic bases. In addition to directly considering the
resulting linkage signal we also test whether our weighting scheme
significantly improves the evidence for linkage.
We obtained phenotype and genotype data on 711 pedigrees
(5,364 individuals) from the National Institute of Mental Health
Genetics Initiative for BP. This sample was collected over 15 years
at 10 sites across the country. Methods for collection of this
sample have been described elsewhere [Dick et al., 2003; McInnis
et al., 2003]. Diagnostic assessment was done using the Diagnostic
Interview for Genetic Studies [Nurnberger et al., 1994], and psy-
chiatric diagnoses including mood and substance use disorder
diagnoses were assigned using a best-estimate process [Leckman
et al., 1982]. Within that sample, four disorders were of interest:
BPI (N¼ 956), schizoaffective disorder-bipolar type (SAB)
(N¼ 72), BPII (N¼ 128), and major depressive disorder-recurrent
(MDDR) (N¼ 148). We classified subjects into three affectation
status models. Model 1 included 635 families with subjects affected
by SAB or BPI, model 2 included 637 families affected by SAB,
BPI, or BPII, and model 3 included 638 families affected by SAB,
BPI, BPII, or MDDR.
Information on alcohol use was collected for 1,835 of these
persons; 64% of this subsample were female, and the mean age of
interview was 43. The mean age of onset of BP was significantly
reduced in both the AA (P¼ 0.006, t-test) and AD (P¼ 7.2 106,
t-test) groups. AD in BP families was associated with a smaller
likelihood of being currently married (P¼ 1.6 105,c2-test, 1 df),
lower mean number of school years (P¼ 3.0 107, c2-test, 1 df),
lower mean number of children (P¼ 0.009, c2-test, 1 df), and more
episodes of illness (P¼ 0.015, c2-test, 1 df).
Individuals were typed for 391 microsatellite markers with an
average spacing of 9 cM and average heterozygosity of 0.76 from
a modification of the Cooperative Human Linkage Center version
9 [Dick et al., 2003; McInnis et al., 2003]. We used GENEHUNTER-
PLUS (GHP) [Kruglyak et al., 1996] to perform multipoint non-
parametric linkage analyses using the allele-sharing model (ASM)
[Kong and Cox, 1997] analysis found in the GHP package calcu-
lating an NPL-score for each locus.
To weight for each pedigree by family levels of AA, we counted
the number of individuals with AA in a family regardless of affection
status and divided this count by the total number of family
members with information known regarding alcohol abuse or
dependence. We generated weights for family levels of AD analo-
gously. Under this weighting scheme, 510 families based on AA and
355 families based on AD had a weight of zero (Fig. 1) and were thus
ignored in the linkage analysis.
Using these weights, we recalculated NPL-scores for each family
and each locus in the genome. Note that families with a weight of
zero do not contribute to the evidence for linkage. To assess the
significance of the observed increase in NPL score, we performed
permutation studies. In each replication, we randomly reassigned
the AA weights to the 711 families. Using the randomized weight
file we repeated the ASM analysis and recorded the maximum NPL
score. The process was repeated 1,000 times providing an empirical
distribution. Comparing this empirical distribution with NPL
scores generated using the original AA weighting, we generated
P-values for these observations. We analogously generated P-values
for NPL-scores based on AD weights.
Using AA weighting and affection status model 1, we observed
a maximum NPL score of 3.23, with a corresponding LOD of 2.77.
This linkage peak was located on chromosome 9p22.2, at 38.45 cM
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marker D9S925 (Fig. 2). This NPL score is a substantive improve-
ment over the NPL-score generated using uniform weights (1.74).
Nevertheless, the LOD score does not meet genome-wide signifi-
cance standard of 3.3; however it is higher than the threshold of 1.9
for suggestive linkage [Lander and Kruglyak, 1995]. Permutation
analysis indicated that the improved signal for linkage at 9p22.2
is higher than expected by chance (P¼ 0.048) and thus likely a
result of our weighting scheme. The second strongest signal gener-
ated using weighting by AA was located on chromosome 3p14 at
77.12 cM, marker D3S4542. The NPL of 2.94 and LOD of 2.53
observed at this locus were above the threshold for suggestive
linkage as well. Weighting on AD, we did not observe any regions
FIG. 1. Number of families with each alcohol abuse (left) or alcohol dependence (right) weight. Weights are a proportion calculated by the number
of family members with AA or AD divided by the total number of family members.
FIG. 2. A suggestive area of linkage at 9p22 (NPL 3.23) with alcohol abuse (AA) weight. This region showed significant difference from the NPL score
without weighting or with alcohol dependence (AD) weight.
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with strong linkage. The strongest signal we observed using model 3
affectation status was an NPL score of 2.41 found on chromosome 8,
p23.2 at 4.30 cM with a corresponding LOD of 2.03. The weighting
scheme actually decreased the NPL score; the unweighted score
was 2.53.
In summary, we identified a suggestive linkage signal for bipolar
disorder on chromosomal region 9p22 after weighting families by
frequency of AA. This locus was previously identified as a region of
suggestive linkage in bipolar disorder in a recent meta-analysis
[Segurado et al., 2003]. This meta-analysis was mostly influenced
by two unrelated samples, the Wellcome Trust UK-Irish sample
[Bennett et al., 2002], and an unpublished study in Australia.
However, further replication is necessary to affirm this finding.
Using permutation, we showed that our weighting scheme
significantly enhanced the linkage signal, generating a maximum
NPL score that is higher than expected by chance. The statistical
significance of the linkage result indicates an increased effect of the
detected locus in families with high levels of AA. To further evaluate
the nature of this interaction, consider that the weighting scheme
included family members with AA regardless of mood disorder.
By not restricting the weighting to family members affected by
mood disorder, we assumed a risk variant that jointly increases the
risk for AA and BP disorder. Such an allele is most likely to segregate
in families with large numbers of individuals affected with AA.
However, an equally valid interpretation of our results is a risk
variant on 9p22 that has a particularly high effect size in a difficult
home environment generated by high familial levels of AA. Further
investigation is needed to separate these hypotheses.
Remarkably, after weighting for AD, we do not observe any
significantly improved linkage signal for BP. This is surprising
given the evidence for familiality of AD. In a non-bipolar sample
in a study of the genetics of alcoholism, the Collaborative Studies of
Genetics of Alcoholism sample, AD but not AA, was demonstrated
to be highly familial [Nurnberger et al., 2004]. Several studies of
familiality of alcoholism in bipolar samples have not differentiated
between AA and AD phenotypes [Winokur et al., 1996; Schulze
et al., 2005, 2006; Potash et al., 2008; Saunders et al., 2008]; one
study in the NIMH GI dataset revealed that relatives of probands
with affective disorders (particularly BPI and SAB) were more
likely to have AD, but AA was not studied [Nurnberger et al.,
2007]. Given these findings, it is surprising that we detect a signal
with AA weighting and not AD weighting. While this result may
simply be explained by low power of our approach, this seems
unlikely as the number of families with nonzero AD weight is almost
twice as high as the number of families with nonzero AA weight.
More likely, the interaction between BP and AD is not captured by
our weighting scheme. We refrained from testing a wider range of
weighting schemes, as applying multiple schemes would require
adjusting for multiple testing and we are unlikely to have sufficient
power to overcome the associated penalty.
If there truly is a risk variant for BP that is present in AA families
and not AD families, it may predispose individuals to impulsive
behaviors that then take the form of alcohol abuse during mood
episodes. Mood-dependent drinking occurs frequently in BP
[reviewed in Goodwin and Jamison, 2007], and is an area of
significant concern clinically, as alcohol abuse causes legal and
social problems which add to the devastating toll of BP.
AA and AD are both potentially useful markers for defining
subtypes of BP and exploring their interaction with genetic risk
factors may thus further the understanding of its heterogeneity.
Hence, the demonstrated interaction between AA and BP may
help identifying subtypes of BP and tailor treatment strategies to
the patient.
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